Meeting
2012 Gastrointestinal Cancers Symposium
Phase I study of weekly intraperitoneal paclitaxel combined with S-1 and oxaliplatin for gastric cancer with peritoneal metastasis.
Authors
Hironori Ishigami
Department of Outpatient Chemotherapy, The University of Tokyo, Tokyo, Japan
Hironori Ishigami , Shoichi Kaisaki , Hironori Yamaguchi , Hiroharu Yamashita , Shigenobu Emoto , Joji Kitayama
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: Cancers of the Esophagus and Stomach
Track
Cancers of the Esophagus and Stomach
Sub Track
Multidisciplinary Treatment
Clinical Trial Registration Number
UMIN000004978
Citation
J Clin Oncol 30, 2012 (suppl 4; abstr 146)
DOI
10.1200/jco.2012.30.4_suppl.146
Abstract #
146
Poster Bd #
D18
Abstract Disclosures
Similar Posters
Poster
2016 Gastrointestinal Cancers Symposium
Phase I study of intraperitoneal paclitaxel combined with S-1 plus cisplatin for gastric cancer with peritoneal metastasis.
First Author: Daisuke Kobayashi
Poster
2020 ASCO Virtual Scientific Program
Phase II study of intraperitoneal paclitaxel combined with S-1 plus cisplatin for gastric cancer with peritoneal metastasis: SP + IP PTX trial.
First Author: Daisuke Kobayashi
Poster
2017 ASCO Annual Meeting
Phase II study of intraperitoneal docetaxel plus capecitabine/cisplatin for gastric cancer with peritoneal metastasis: XP+IP DOC trial.
First Author: Ryoji Fukushima
Poster
2016 ASCO Annual Meeting
Phase II study of intraperitoneal paclitaxel plus S-1/oxaliplatin for gastric cancer with peritoneal metastasis: SOX+IP PTX trial.
First Author: Yoshiyuki Fujiwara